The Effect of Age on First-line Chemotherapy for Epithelial Ovarian Cancer and Primary Peritoneal Carcinoma

被引：4
|
作者：
Larbi, E. [1 ]
Madhuri, K. [1 ]
Essapen, S. [1 ]
Butler-Manuel, S. [1 ]
Tailor, A. [1 ]
Michael, A. [2 ]
机构：
[1] Royal Surrey Cty Hosp, St Lukes Canc Ctr, Guildford, Surrey, England
[2] Univ Surrey, Postgrad Med Sch, Guildford GU2 5XH, Surrey, England
来源：
CLINICAL ONCOLOGY | 2013年 / 25卷 / 01期
关键词：
D O I：
10.1016/j.clon.2012.09.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [31] First-Line Chemotherapy for Ovarian Cancer: Inferences From Recent Studies
    Rose, Peter G.
    [J]. ONCOLOGIST, 2016, 21 (11): : 1286 - 1290
  • [32] Intraperitoneal chemotherapy in first-line combination treatment for advanced ovarian cancer
    Massard, Christophe
    Lhomme, Catherine
    Pautier, Patricia
    [J]. BULLETIN DU CANCER, 2007, 94 (04) : 398 - 404
  • [33] The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer
    Drisko, JA
    Chapman, J
    Hunter, VJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2003, 22 (02) : 118 - 123
  • [34] First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence
    J Sandercock
    MKB Parmar
    V Torri
    [J]. British Journal of Cancer, 1998, 78 : 1471 - 1478
  • [35] Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting
    Antonio González-Martín
    Gemma Toledo
    Luis Chiva
    [J]. Clinical and Translational Oncology, 2010, 12 : 418 - 430
  • [36] Pazopanib (Paz) monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, Fallopian tube, or primary peritoneal carcinoma
    Zang, Rongyu
    Wu, Lingying
    Zhu, Jianqing
    Kong, Beihua
    Kim, Byoung-Gie
    Yao, Yuanquing
    Yin, Rutie
    Liu, Jihong
    Wu, Qiang
    Ngan, Hextan Yuen Sheung
    Xie, Xing
    Wang, Kung-Liahng
    Li, Xiuqin
    Yen, Ming-Shyen
    Wei, Lihui
    Wang, Qiong
    Mitrica, Ionel
    Carpenter, Christopher
    Zhang, Pingkuan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting
    Gonzalez-Martin, Antonio
    Toledo, Gemma
    Chiva, Luis
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2010, 12 (06): : 418 - 430
  • [38] The effect of protocol inclusion on the outcomes of ovarian cancer patients receiving first-line chemotherapy.
    Brown, AK
    Donfrancesco, S
    Granai, CO
    Disilvestro, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 471S - 471S
  • [39] Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer
    P A Vasey
    R Atkinson
    R Coleman
    M Crawford
    M Cruickshank
    P Eggleton
    D Fleming
    J Graham
    D Parkin
    J Paul
    N S Reed
    S B Kaye
    [J]. British Journal of Cancer, 2001, 84 : 170 - 178
  • [40] Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer
    Vasey, PA
    Atkinson, R
    Coleman, R
    Crawford, M
    Cruickshank, M
    Eggleton, P
    Fleming, D
    Graham, J
    Parkin, D
    Paul, J
    Reed, NS
    Kaye, SB
    [J]. BRITISH JOURNAL OF CANCER, 2001, 84 (02) : 170 - 178
12345